Holdings

ACT Capital Partners, L.P.

As of Sep 30, 2026, ACT Capital Partners, L.P. reported 53 positions worth US$139M. Largest: Chevron Corporation, Krystal Biotech, Inc. and TG Therapeutics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Chevron Corporation75,000US$15.3Mfirst reportSep 30, 2026
Krystal Biotech, Inc.42,000US$14Mfirst reportSep 30, 2026
TG Therapeutics, Inc.237KUS$13.2Mfirst reportSep 30, 2026
Amazon.com, Inc.42,500US$10.6Mfirst reportSep 30, 2026
Abivax SA85,000US$8.42Mfirst reportSep 30, 2026
Viking Therapeutics, Inc.220KUS$7.18Mfirst reportSep 30, 2026
SK hynix Inc.34,700US$6.39Mfirst reportSep 30, 2026
Arrowhead Pharmaceuticals, Inc.94,000US$6.15Mfirst reportSep 30, 2026
Nektar Therapeutics90,400US$5.47Mfirst reportSep 30, 2026
Tesla, Inc.14,800US$5.25Mfirst reportSep 30, 2026